FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION Sample Clauses
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION or representative shall have entered into a non-disclosure agreement in respect of such Confidential Information in favour of the Discloser on terms requiring at least [**] years of confidentiality from the date of disclosure of such Confidential Information but that are in all other respects materially similar to the provisions of this clause 12. For greater certainty, BIS’ representatives shall include the DLA Contract Authority, the DLA Project Manager and all representatives of members of [**].
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PROBLEM REPORT
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. To the extent possible, DMD will seek insurance coverage and will tender any defense to an insurer affording coverage.
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. >. Commencing with a First Commercial Sale BTC will pay running royalties on a specified percentage of Net Sales of Licensed Products on a country-by-country and product by product basis as follows:
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. All other provisions of the Agreement shall remain unaltered and be given full force and effect. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Agreement.
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. so excluded, without invalidating the remaining provisions of this Agreement; and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS 11 presentations. Each party shall be responsible for its respective sales expenses. Any sales prospect for which ROCKWELL requested joint sales effort shall not be solicited by VOICETEK alone, unless mutually agreed to in writing.
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SCHEDULE 1.3.2 DIGIMARC INFORMATION TECHNOLOGY SERVICES
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT) days after any breakage or defect in an Item becomes apparent, whether or not said breakage or defect can reasonably be expected to occur in any other Aircraft, and the Buyer shall inform the Seller in sufficient detail about the breakage or defect to enable the Seller to determine whether said breakage or defect is subject to this Service Life Policy.
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. All other provisions of the Agreement remain unchanged and in full force and effect. TUFTS UNIVERSITY PARATEK PHARMACEUTICALS, INC. By: /s/ Xxxxxx X. Xxxxx By: /s/ Xxxxxx X. Xxxxxxx (signature) (signature) Xxxxxx X. Xxxxx Xxxxxx X. Xxxxxxx Name Name Senior Director, University Development Executive Vice President Title Title 12/23/97 12/29/97 TUFTS UNIVERSITY -- PARATEK PHARMACEUTICALS, INC. AMENDMENT NO. 2 TO LICENSE AGREEMENT DATED FEBRUARY 1, 1997 Exhibit A is hereby amended to include: • Patent application entitled: "[***]" Continuation in Part of U.S. patent No.: [***], Filed [***], Notice of Allowance [***]. • Provisional patent application entitled: "[***]", Serial No.: [***], Filed [***] • Patent application jointly owned with [***], entitled: "[***]", Serial No.: [***], Filed [***] • Provisional patent application entitled: "[***]", Serial No.: [***], Filed [***] • Patent application entitled: "[***]", Serial No.: [***], Filed [***] • Patent application entitled: "[***]", U.S. patent No. [***], Issued [***], Divisional Application of U.S. patent No. [***] All other provisions of the Agreement remain unchanged and in full force and effect. TUFTS UNIVERSITY PARATEK PHARMACEUTICALS, INC. By: /s/ Xxxxxxxx Xxxxxx By: /s/ Xxxxxx X. Xxxxxxx (signature) (signature) Xxxxxxxx Xxxxxx Xxxxxx X. Xxxxxxx Name Name Executive Vice President and Associate Xxxxxxx for Research Chief Operating Officer Title Title 7/31/98 7/31/98 Date Date TUFTS UNIVERSITY - PARATEK PHARMACEUTICALS, INC AMENDMENT NO. 3 TO LICENSE AGREEMENT DATED FEBRUARY 1, 1997 Exhibit A and all amendments and modifications are deleted and replaced in their entirety by the attached Exhibit X. Xxxxx’ ownership interests in all patents, patent applications and disclosures listed in the attached Exhibit A are hereby incorporated into the License Agreement dated February 1, 1997. All other provisions of the Agreement as amended remain in full force and effect.